GSK Strikes $613M Deal With Omega For OTC Brands, Plant
Per the deal, Belgium-based Omega will be snatching up antacid, pain relief and other brands that generated approximately £185 million in 2011. It will also be taking over a German manufacturing plant and its 110 employees, according to GSK.
Pending regulatory approval, the transaction is expected to...
To view the full article, register now.